glp 1 hormone medication GLP-1 weight-loss drugs may also curb alcohol cravings Prescription GLP-1s for Weight Loss

Immortalization of human normal and NF1 neurofibroma Schwann cells

Positive correlations with SA were identified for all risk factors: BMI (OR 1.51 [95%CI 1.471.56], P = 4.08 10 162 ), current tobacco smoking (OR 1.21 [95%CI 1.061.38], P = 5.45 10 3 ), and alcohol consumption (OR 1.12 [95% CI 1.001.24], P = 4.42 10 2 )

Clin Chim Acta 339:3341 Ha J, Choi HS, Lee Y, Lee ZH, Kim HH (2009) Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos

[31] A large study found that GLP-1 RA use was associated with lower risk of developing immune-mediated inflammatory diseases in patients with type 2 diabetes or obesity, suggesting a potential protective effect in some cohorts.[42] What the science is showing is potential for improvements: GLP-1RAs reduce blunt activation in fibroblast-like synoviocytes and improve joint inflammation and metabolic parameters in rheumatoid arthritis models and small human cohorts.[26][29][25] [31] Early clinical studies and case series in RA patients (especially those with coexisting type 2 diabetes or obesity) reported reduced disease activity scores (DAS28), lower C-reactive protein and erythrocyte sedimentation rate levels, fewer swollen joints, and diminished morning stiffness during GLP-1RA treatment, along with the expected weight reduction and improved insulin sensitivity.[31] Psoriasis showed improved PASI scores and quality-of-life metrics in patients with T2DM and psoriasis, alongside reductions in lesional skin and peripheral TNF-producing monocytes.[26] Case series show meaningful skin improvement.[26] In psoriasis and psoriatic arthritis , GLP-1RA therapy has been associated with improvements in inflammatory markers and disease severity indices